8/26/24 17:40 | 8/22/24 | TXMD | Health | Drug | Pharmaceutical Preparations | Collins Cooper C. | FL | D | | P | 7 | 1.73 | 0 | 4 | 9 | 52 | D | | | | | | | | | | | | | | |
8/23/24 18:18 | 8/21/24 | TXMD | Health | Drug | Pharmaceutical Preparations | Collins Cooper C. | FL | D | | P | 2 | 1.70 | 0 | 1 | 3 | 48 | D | | | | | | | | | | | | | | |
12/7/23 16:51 | 12/5/23 | TXMD | Health | Drug | Pharmaceutical Preparations | Walker Marlan D | FL | O | CEO | M.d | 0 | 0.00 | 0 | 70 | | 63 | D | | | | | | | | | | | | | | |
12/7/23 16:51 | 12/6/23 | TXMD | Health | Drug | Pharmaceutical Preparations | Walker Marlan D | FL | O | CEO | S.dm | -44 | 2.29 | 0 | -19 | -23 | 63 | D | | | | | | | | | | | | | | |
5/4/23 16:38 | 4/26/23 | TXMD | Health | Drug | Pharmaceutical Preparations | Walker Marlan D | FL | O | CEO | M.ad | 0 | 0.00 | 0 | 3 | 31 | 12 | D | | | | | | | | | | | | | | |
5/4/23 16:38 | 4/26/23 | TXMD | Health | Drug | Pharmaceutical Preparations | Walker Marlan D | FL | O | CEO | S.ad | -3 | 3.64 | 0 | -1 | -6 | 12 | D | | | | | | | | | | | | | | |
4/14/23 19:20 | 4/12/23 | TXMD | Health | Drug | Pharmaceutical Preparations | Walker Marlan D | FL | O | CEO | M.d | 0 | 0.00 | 0 | 8 | 156 | 12 | D | | | | | | | | | | | | | | |
4/14/23 19:20 | 4/12/23 | TXMD | Health | Drug | Pharmaceutical Preparations | Walker Marlan D | FL | O | CEO | S.d | -4 | 3.65 | 0 | -1 | -9 | 12 | D | | | | | | | | | | | | | | |
4/14/23 19:17 | 4/12/23 | TXMD | Health | Drug | Pharmaceutical Preparations | Donegan Michael C | FL | O | Prin. Fi | M.d | 0 | 0.00 | 0 | 50 | 422 | 62 | D | | | | | | | | | | | | | | |
1/30/23 18:40 | 1/26/23 | TXMD | Health | Drug | Pharmaceutical Preparations | Donegan Michael C | FL | O | Prin. Fi | M.d | 0 | 0.00 | 0 | 6 | 100 | 12 | D | | | | | | | | | | | | | | |
1/30/23 18:40 | 1/26/23 | TXMD | Health | Drug | Pharmaceutical Preparations | Donegan Michael C | FL | O | Prin. Fi | S.dm | -9 | 5.08 | 0 | -2 | -13 | 12 | D | | | | | | | | | | | | | | |
1/25/23 17:50 | 1/23/23 | TXMD | Health | Drug | Pharmaceutical Preparations | Donegan Michael C | FL | O | Prin. Fi | M.d | 0 | 0.00 | 0 | 4 | 135 | 8 | D | | | | | | | | | | | | | | |
1/25/23 17:50 | 1/23/23 | TXMD | Health | Drug | Pharmaceutical Preparations | Donegan Michael C | FL | O | Prin. Fi | S.dm | -7 | 5.34 | 0 | -1 | -15 | 8 | D | | | | | | | | | | | | | | |
1/3/23 15:33 | 12/30/22 | TXMD | Health | Drug | Pharmaceutical Preparations | Rubric Capital Management LP | NY | T | | S | -38,657 | 1,333.0 | 0 | -29 | -100 | 0 | I | | | | | | | | | | | | | | |
12/12/22 11:14 | 12/9/22 | TXMD | Health | Drug | Pharmaceutical Preparations | Rubric Capital Management LP | NY | T | | P | 90 | 6.09 | 0 | 15 | 1 | 1,757 | I | | | | | | | | | | | | | | |
12/9/22 19:41 | 12/6/22 | TXMD | Health | Drug | Pharmaceutical Preparations | Bernick Brian | FL | O | Co-CEO | M.d | 0 | 0.00 | 0 | 3 | 9 | 39 | D | | | | | | | | | | | | | | |
12/9/22 19:41 | 12/6/22 | TXMD | Health | Drug | Pharmaceutical Preparations | Bernick Brian | FL | O | Co-CEO | S.dm | -7 | 5.28 | 0 | -1 | -3 | 39 | D | | | | | | | | | | | | | | |
12/9/22 19:38 | 12/6/22 | TXMD | Health | Drug | Pharmaceutical Preparations | Walker Marlan D | FL | O | GC | M.d | 0 | 0.00 | 0 | 3 | 62 | 7 | D | | | | | | | | | | | | | | |
12/9/22 19:38 | 12/6/22 | TXMD | Health | Drug | Pharmaceutical Preparations | Walker Marlan D | FL | O | GC | S.d | -5 | 4.95 | 0 | -1 | -14 | 7 | D | | | | | | | | | | | | | | |
12/9/22 19:38 | 12/6/22 | TXMD | Health | Drug | Pharmaceutical Preparations | Glickman Mark A | FL | O | Co-CEO | M.d | 0 | 0.00 | 0 | 2 | | 1 | D | | | | | | | | | | | | | | |
12/9/22 19:38 | 12/6/22 | TXMD | Health | Drug | Pharmaceutical Preparations | Glickman Mark A | FL | O | Co-CEO | S.d | -2 | 4.92 | 0 | 0 | -25 | 1 | D | | | | | | | | | | | | | | |
12/9/22 19:37 | 12/6/22 | TXMD | Health | Drug | Pharmaceutical Preparations | Donegan Michael C | FL | O | Interim | M.d | 0 | 0.00 | 0 | 3 | 322 | 5 | D | | | | | | | | | | | | | | |
12/9/22 19:37 | 12/6/22 | TXMD | Health | Drug | Pharmaceutical Preparations | Donegan Michael C | FL | O | Interim | S.d | -4 | 4.78 | 0 | -1 | -17 | 5 | D | | | | | | | | | | | | | | |
12/9/22 10:58 | 12/7/22 | TXMD | Health | Drug | Pharmaceutical Preparations | Rubric Capital Management LP | NY | T | | P.m | 116 | 5.66 | 0 | 20 | 1 | 3,484 | I | | | | | | | | | | | | | | |
12/8/22 20:10 | 12/7/22 | TXMD | Health | Drug | Pharmaceutical Preparations | Naughton Gail K | FL | D | | S | -21 | 5.26 | 0 | -4 | -100 | 0 | D | | | | | | | | | | | | | | |
10/31/22 12:12 | 10/28/22 | TXMD | Health | Drug | Pharmaceutical Preparations | Rubric Capital Management LP | NY | T | | P | 7,000 | 1,000.0 | 0 | 7 | 32 | 29 | I | | | | | | | | | | | | | | |
10/3/22 17:40 | 9/30/22 | TXMD | Health | Drug | Pharmaceutical Preparations | Rubric Capital Management LP | NY | T | | P | 7,000 | 1,000.0 | 0 | 7 | 47 | 22 | I | | | | | | | | | | | | | | |
8/22/22 06:00 | 8/18/22 | TXMD | Health | Drug | Pharmaceutical Preparations | Collins Cooper C. | FL | D | | M.d | 0 | 0.00 | 0 | 2 | 4 | 47 | D | | | | | | | | | | | | | | |
8/22/22 06:00 | 8/18/22 | TXMD | Health | Drug | Pharmaceutical Preparations | Naughton Gail K | FL | D | | M.d | 0 | 0.00 | 0 | 2 | 102 | 4 | D | | | | | | | | | | | | | | |
8/22/22 06:00 | 8/18/22 | TXMD | Health | Drug | Pharmaceutical Preparations | Musing Jules A. | FL | D | | M.d | 0 | 0.00 | 0 | 2 | 97 | 4 | D | | | | | | | | | | | | | | |
8/22/22 06:00 | 8/18/22 | TXMD | Health | Drug | Pharmaceutical Preparations | Russell Angus C. | FL | D | | M.d | 0 | 0.00 | 0 | 2 | 52 | 6 | D | | | | | | | | | | | | | | |
8/22/22 06:00 | 8/18/22 | TXMD | Health | Drug | Pharmaceutical Preparations | Ling Karen | FL | D | | M.d | 0 | 0.00 | 0 | 2 | 76 | 5 | D | | | | | | | | | | | | | | |
8/22/22 06:00 | 8/18/22 | TXMD | Health | Drug | Pharmaceutical Preparations | Thompson Tommy G | FL | D | | M.d | 0 | 0.00 | 0 | 3 | 17 | 20 | D | | | | | | | | | | | | | | |
8/22/22 06:00 | 8/18/22 | TXMD | Health | Drug | Pharmaceutical Preparations | Bisaro Paul | FL | D | | M.d | 0 | 0.00 | 0 | 2 | 50 | 6 | D | | | | | | | | | | | | | | |
8/1/22 18:11 | 7/29/22 | TXMD | Health | Drug | Pharmaceutical Preparations | Rubric Capital Management LP | NY | T | | P | 15,000 | 25.86 | 0 | 580 | 50 | 1,737 | I | | | | | | | | | | | | | | |
7/19/22 11:28 | 7/15/22 | TXMD | Health | Drug | Pharmaceutical Preparations | Rubric Capital Management LP | NY | T | | P.m | 467 | 5.66 | 0 | 83 | 4 | 2,296 | I | | | | | | | | | | | | | | |
3/15/22 07:00 | 3/14/22 | TXMD | Health | Drug | Pharmaceutical Preparations | Walker Marlan D | FL | O | GC | M.d | 0 | 0.00 | 0 | 230 | 796 | 259 | D | | | | | | | | | | | | | | |